Maktaba

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague.

Authors : Guo X; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.; Xin Y

Subjects: Yersinia pestis*/Yersinia pestis*/Yersinia pestis*/genetics ; Vaccines* ; Plague Vaccine*/Plague Vaccine*/Plague Vaccine*/genetics

Source: PLoS pathogens [PLoS Pathog] 2024 Mar 28; Vol. 20 (3), pp. e1012129. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague.

Authors : Davies ML; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States.; Biryukov SS

Subjects: Plague*/Plague*/Plague*/prevention & control ; Plague*/Plague*/Plague*/immunology ; Yersinia pestis*/Yersinia pestis*/Yersinia pestis*/immunology

Source: Frontiers in immunology [Front Immunol] 2024 May 21; Vol. 15, pp. 1397579. Date of Electronic Publication: 2024 May 21 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice.

Authors : Galloway DR; Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, United States.; Li J

Subjects: Plague Vaccine* ; Yersinia pestis*; Humans

Source: Frontiers in immunology [Front Immunol] 2024 Mar 28; Vol. 15, pp. 1277526. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

Protection Induced by Oral Vaccination with a Recombinant Yersinia pseudotuberculosis Delivering Yersinia pestis LcrV and F1 Antigens in Mice and Rats against Pneumonic Plague.

Authors : Majumder S; Department of Immunology and Microbial Disease, Albany Medical College, Albany, New York, USA.; Olson RM

Subjects: Plague*/Plague*/Plague*/prevention & control ; Plague Vaccine* ; Yersinia pestis*/Yersinia pestis*/Yersinia pestis*/genetics

Source: Infection and immunity [Infect Immun] 2022 Aug 18; Vol. 90 (8), pp. e0016522. Date of Electronic Publication: 2022 Jul 28.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0246127 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list

Academic Journal

Moderate Susceptibility to Subcutaneous Plague (Yersinia pestis) Challenge in Vaccine-Treated and Untreated Sonoran Deer Mice (Peromyscus maniculatus sonoriensis) and Northern Grasshopper Mice (Onychomys leucogaster).

Authors : Bron GM; University of Wisconsin, School of Veterinary Medicine, Department of Pathobiological Sciences, 1656 Linden Drive, Madison, Wisconsin 53706, USA.; Smith SR

Subjects: Plague Vaccine* ; Rodent Diseases*/Rodent Diseases*/Rodent Diseases*/microbiology ; Rodent Diseases*/Rodent Diseases*/Rodent Diseases*/prevention & control

Source: Journal of wildlife diseases [J Wildl Dis] 2021 Jul 01; Vol. 57 (3), pp. 632-636.Publisher: Wildlife Disease Association Country of Publication: United States NLM ID: 0244160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation.

Authors : Zhang W; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.; Song X

Subjects: Plague/Plague/Plague/*prevention & control ; Plague Vaccine/Plague Vaccine/Plague Vaccine/*immunology ; Vaccines, Subunit/Vaccines, Subunit/Vaccines, Subunit/*immunology

Source: Frontiers in immunology [Front Immunol] 2022 Jan 26; Vol. 13, pp. 793382. Date of Electronic Publication: 2022 Jan 26 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium.

Authors : Kon E; Laboratory of Precision NanoMedicine, Shmunis School for Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.; Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv 69978, Israel.

Subjects: Plague*/Plague*/Plague*/prevention & control ; Plague Vaccine*/Plague Vaccine*/Plague Vaccine*/genetics ; Yersinia pestis*/Yersinia pestis*/Yersinia pestis*/genetics

Source: Science advances [Sci Adv] 2023 Mar 10; Vol. 9 (10), pp. eadg1036. Date of Electronic Publication: 2023 Mar 08.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic

Record details

Read More Add to Saved list

Academic Journal

Construction of a Live-Attenuated Vaccine Strain of Yersinia pestis EV76-B-SHUΔ pla and Evaluation of Its Protection Efficacy in a Mouse Model by Aerosolized Intratracheal Inoculation.

Authors : Feng J; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.; Capital Institute of Pediatrics, Beijing, China.

Subjects: Plague*/Plague*/Plague*/prevention & control ; Plague Vaccine* ; Yersinia pestis*

Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2020 Sep 08; Vol. 10, pp. 473. Date of Electronic Publication: 2020 Sep 08 (Print Publication: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine.

Authors : Biryukov S; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States.; Dankmeyer JL

Subjects: Adjuvants, Immunologic*; Antigens, Bacterial/Antigens, Bacterial/Antigens, Bacterial/*immunology ; Plague/Plague/Plague/*prevention & control

Source: Frontiers in immunology [Front Immunol] 2021 Aug 27; Vol. 12, pp. 726416. Date of Electronic Publication: 2021 Aug 27 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list

Academic Journal

Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.

Authors : Bowen W; Institute for Cellular Therapeutics, University of Louisville, Louisville, KY 40202, United States; FasCure Therapeutics, LLC, Louisville, KY 40202, United States.

Subjects: Immunity, Humoral*; Plague/Plague/Plague/*immunology ; Plague/Plague/Plague/*prevention & control

Source: Vaccine [Vaccine] 2019 Sep 10; Vol. 37 (38), pp. 5708-5716. Date of Electronic Publication: 2019 Aug 12.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Search Results

Your Filters

A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague.

Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague.

Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice.

Protection Induced by Oral Vaccination with a Recombinant Yersinia pseudotuberculosis Delivering Yersinia pestis LcrV and F1 Antigens in Mice and Rats against Pneumonic Plague.

Moderate Susceptibility to Subcutaneous Plague (Yersinia pestis) Challenge in Vaccine-Treated and Untreated Sonoran Deer Mice (Peromyscus maniculatus sonoriensis) and Northern Grasshopper Mice (Onychomys leucogaster).

Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation.

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium.

Construction of a Live-Attenuated Vaccine Strain of Yersinia pestis EV76-B-SHUΔ pla and Evaluation of Its Protection Efficacy in a Mouse Model by Aerosolized Intratracheal Inoculation.

Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine.

Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.